,,ii #aahth ,,congress #ast ,session ,s4 #cbai ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,november #b1 #bjbc,ms4 ,baldwin 7for herself1 ,ms4 ,klobuchar1 ,mr4 ,blumenthal1 and ,ms4 ,smith7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to protect against seasonal and pandemic influenza1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,protecting ,america from ,seasonal and ,pandemic ,influenza ,act of #bjbc or the ,influenza ,act4 #b4 ,findings ,congress finds the following3 7#a7 ,influenza occurs seasonally each year1 and1 throughout history1 has caused devastating pandemics4 ,the #aiah influenza pandemic killed an estimated #fge1jjj people in the ,united ,states4 7#b7 ,in an average season1 influenza results in #ab1jjj to #eb1jjj deaths in the ,united ,states1 including over #ajj pediatric deaths4 ,additionally1 influenza causes hundreds of thousands of hospitalizations and millions of illnesses4 7#c7 ,the ,council of ,economic ,advisors issued a report in #bjai estimating that seasonal influenza costs the ,united ,states approximately #cfa1jjj1jjj1jjj per year1 and that an influenza pandemic has the potential to cause up to #c1gij1jjj1jjj1jjj in losses4 ,this report was issued prior to the ,,covid-#ai pandemic1 which will cost the ,united ,states an estimated #af1jjj1jjj1jjj1jjj4 7#d7 ,most funding for pandemic influenza preparedness up until fiscal year #bjah was derived from supplemental appropriations that dated back to the #bjji ,h#a,n#a pandemic4 7#e7 ,centers for ,disease ,control and ,prevention 7referred to in this section as the ,,cdc7 studies of influenza hospitalization rates by race and ethnicity during #aj influenza seasons from #bjji to #bjai showed that individuals from racial and ethnic minority groups are at higher risk for being hospitalized with influenza4 7#f7 ,the ,,covid-#ai pandemic response has been built on the pandemic influenza response ecosystem4 7#g7 ,strategies that increase seasonal influenza vaccination rates will also improve pandemic readiness4 7#h7 ,the ,national ,influenza ,vaccine ,modernization ,strategy of #bjbj-bjcj of the ,department of ,health and ,human ,services should be implemented as quickly as possible to ensure the ,nation's vaccine enterprise is highly responsive1 flexible1 scalable1 and effective at reducing the impact of seasonal and pandemic influenza viruses4 7#i7 ,influenza surveillance has been improved significantly through advances in next-generation gene sequencing tools to analyze circulating influenza viruses4 ,the technology allows the ,,cdc to study more influenza viruses faster and in more detail1 and to monitor genetic changes in influenza viruses to better understand and improve the effectiveness of influenza vaccines4 7#aj7 ,influenza diagnosis and surveillance has improved significantly through advances in influenza testing4 ,timely infection control and prevention strategies would be significantly bolstered by accurate and readily accessible at-home diagnostic tests4 ,rapid diagnostics can improve access for underserved populations and allow for better antibiotic stewardship4 7#aa7 ,vaccine hesitancy in the ,united ,states has reached a tipping point where it is adversely affecting public health4 ,misinformation is widely available on social media1 and traditional sources of information on the value and efficacy of vaccines are not trusted by many people of the ,united ,states1 especially those who are vaccine hesitant4 7#ab7 ,support for vaccine communication1 outreach1 and administration across public health and health care settings is critical to drive demand of influenza vaccines1 treatments1 and medical countermeasures and ensure equitable uptake of such innovations4 #c4 ,strengthening and diversifying influenza vaccine1 therapeutics1 and diagnostics development1 manufacturing1 and supply chain 7a7 ,timely delivery of first doses of finished influenza vaccine 7#a7 ,national goal ,it is a national goal for the ,united ,states to have1 not later than #c years after the date of enactment of this ,act1 the capacity to deliver first doses of finished influenza vaccine within #ab weeks of emergence of an influenza strain with pandemic potential4 7#b7 ,plan ,not later than #f months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,assistant ,secretary for ,preparedness and ,response and the ,director of the ,biomedical ,advanced ,research and ,development ,authority1 shall publish a plan to achieve the goal specified in paragraph 7#a74 7b7 ,universal influenza vaccine 7#a7 ,national goal ,it is a national goal for the ,united ,states to have developed a universal influenza vaccine1 not later than #aj years after the date of enactment of this ,act4 7#b7 ,plan 7,a7 ,publication ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,director of the ,national ,institutes of ,health and the ,director of the ,biomedical ,advanced ,research and ,development ,authority1 shall publish a plan to achieve the goal specified in paragraph 7#a7 in partnership with vaccine manufacturers4 7,b7 ,interim support ,the plan under subparagraph 7,a7 shall include provisions1 as necessary to achieve such goal1 for support over the period of #e years following the publication of such plan of the following3 7i7 ,incremental vaccine efficacy improvements4 7ii7 ,the research workforce4 7c7 ,strengthening the vaccine supply chain 7#a7 ,public-private partnerships 7,a7 ,in general ,the ,secretary of ,health and ,human ,services shall-- 7i7 establish public-private partnerships to strengthen the domestic vaccine supply chain2 and 7ii7 evaluate the capabilities1 capacity1 and utilization of such partnerships1 including by assessing and testing relevant logistical and interoperable technology with stakeholders in the supply chain4 7,b7 ,domestic vaccine supply chain ,for purposes of this paragraph1 the term domestic vaccine supply chain includes the full domestic supply chain1 including-- 7i7 production of ingredients and manufacturing and distribution of finished vaccines2 7ii7 fill-finish capacity2 and 7iii7 the supply chain of ancillary supplies such as needles and syringes4 7#b7 ,evaluation of using ,,dpa ,the ,secretary of ,health and ,human ,services1 in coordination with the ,administrator of the ,federal ,emergency ,management ,agency and the ,secretary of ,defense1 shall-- 7,a7 evaluate the use of the ,defense ,production ,act of #aiej 7#ej ,u4,s4,c4 #deja et seq47 for ,,covid-#ai pandemic response2 7,b7 not later than #a year after the date of enactment of this ,act1 complete such evaluation and submit a report to ,congress on the results of such evaluation2 and 7,c7 include in such report-- 7i7 recommendations on using the ,defense ,production ,act of #aiej 7#ej ,u4,s4,c4 #deja et seq47 for building domestic capacity to respond to an influenza pandemic2 and 7ii7 input from external stakeholders4 7d7 ,national ,influenza ,vaccine ,modernization ,strategy ,the ,secretary of ,health and ,human ,services shall-- 7#a7 implement the portions of the ,national ,influenza ,vaccine ,modernization ,strategy #bjbj-bjcj that are within the authority of the ,department of ,health and ,human ,services to carry out 7under other applicable provisions of law72 and 7#b7 by ,june #ae each calendar year through #bjcj1 submit to ,congress a report on such implementation4 7e7 ,assistant ,secretary for ,preparedness and ,response ,section #bhaa of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;hh-#aj7 is amended-- 7#a7 in subsection 7b7-- 7,a7 in paragraph 7#c71 by inserting 1 including the pandemic influenza medical countermeasures program under paragraphs 7#b77;,e7 and 7#d77;,h7 of section #cai,l7c7 after qualified pandemic or epidemic products 7as defined in section #cai;,f-#c72 and 7,b7 in paragraph 7#g71 in the matter preceding subparagraph 7,a71 by inserting 1 including through the pandemic influenza medical countermeasures program under paragraphs 7#b77;,e7 and 7#d77;,h7 of section #cai,l7c7 after for each such threat2 and 7#b7 in subsection 7d77#b7-- 7,a7 in subparagraph 7,j77v71 by striking and at the end2 7,b7 by redesignating subparagraph 7,k7 as subparagraph 7,l72 and 7,c7 by inserting after subparagraph 7,j7 the following3 7,k7 evaluate progress with respect to implementing the ,national ,influenza ,vaccine ,modernization ,strategy1 issued in ,june #bjbj1 or any successor strategy2 and 4 7f7 ,biomedical advanced research and development authority 7#a7 ,preparedness activities ,section #cai,l7c7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#g;e7c77 is amended-- 7,a7 in paragraph 7#b7-- 7i7 in subparagraph 7,c71 by striking and at the end2 7ii7 in subparagraph 7,d71 by striking the period at the end and inserting 2 and2 and 7iii7 by adding at the end of the following3 7,e7 supporting pandemic influenza countermeasure preparedness4 2 and 7,b7 in paragraph 7#d71 by adding at the end of the following3 7,h7 ,pandemic influenza medical countermeasures program ,in carrying out paragraph 7#b77;,e71 the ,secretary shall establish and implement a program that-- 7i7 supports research and development activities for qualified pandemic or epidemic products 7as defined in section #cai;,f-#c71 including by-- 7,i7 developing innovative technologies to enhance rapid response to pandemic influenza threats2 7,,ii7 developing influenza vaccines with potential universal vaccination capability2 7,,iii7 developing enhanced influenza vaccines with longer lasting broad spectrum protective immunity against a wider range of antigenically divergent influenza strains2 7,,iv7 developing alternative vaccine delivery approaches2 7,v7 developing novel small- and large-molecule novel influenza antivirals1 monoclonal antibodies1 and other products that provide better influenza treatment and prevention2 7,,vi7 developing innovative technologies to enhance rapid diagnosis of influenza2 and 7,,vii7 implementing the ,national ,influenza ,vaccine ,modernization ,strategy1 issued in ,june #bjbj1 or any successor strategy2 7ii7 ensures readiness to respond to qualified pandemic and epidemic threats1 including by-- 7,i7 supporting development and manufacturing of influenza virus seeds1 clinical trial lots1 and stockpiles of novel influenza strains2 7,,ii7 supporting the stockpile of influenza antivirals through diversifying and replenishing the existing stockpile of influenza antivirals2 7,,iii7 supporting manufacturing and fill-finish rapid response infrastructure2 7,,iv7 supporting the stockpile of influenza testing equipment and supplies2 and 7,v7 testing and evaluating pandemic threat rapid response capabilities through regular preparedness drills with key public and private sector partners that examine the range of activities 7including production and clinical testing of influenza diagnostics1 vaccines1 and therapeutics7 required to effectively respond to novel threats2 and 7iii7 builds1 sustains1 and replenishes qualified pandemic and epidemic stockpiles of bulk antigen and adjuvant material1 including by-- 7,i7 annually testing the potency and shelflife potential of all existing pandemic and epidemic stockpiles held by the ,department of ,health and ,human ,services2 and 7,,ii7 developing1 and disseminating to key public and private sector partners1 a life cycle management plan4 4 7g7 ,authorization of appropriations ,section #cai,l7d7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#g;e7d77 is amended by adding at the end the following3 7#c7 ,pandemic influenza ,to carry out this section and section #bhaa with respect to pandemic influenza1 in addition to amounts authorized to be appropriated by paragraph 7#b7 and any amounts authorized to be appropriated by section #bhaa1 there is authorized to be appropriated #cce1jjj1jjj for each of fiscal years #bjbd through #bjbh1 to remain available until expended4 4 #d4 ,promoting innovative approaches and use of new technologies to detect1 prevent1 and respond to influenza 7a7 ,sense of ,congress ,it is the sense of ,congress that the ,centers for ,disease ,control and ,prevention should support interoperable immunization information systems that enable bidirectional data exchange among ,states1 localities1 and community immunization providers4 7b7 ,prioritizing influenza1 influenza combination1 and pathogen agnostic tools 7#a7 ,,nih ,the ,director of the ,national ,institutes of ,health may conduct or support basic research prioritizing the development of-- 7,a7 agnostic tools to detect influenza and other pathogens2 and 7,b7 technologies that automate sample preparation for such tools4 7#b7 ,,barda ,the ,director of the ,biomedical ,advanced ,research and ,development ,authority may conduct or support advanced development of novel sequencing modalities prioritizing tools described in paragraph 7#a77;,a7 and technologies described in paragraph 7#a77;,b74 7c7 ,development of point-of-,care and self-,testing diagnostics ,the ,director of the ,biomedical ,advanced ,research and ,development ,authority1 in collaboration with the ,director of the ,centers for ,disease ,control and ,prevention1 the ,director of the ,national ,institutes of ,health1 and the ,commissioner of ,food and ,drugs1 may conduct or support development of rapid1 accurate1 easily accessible1 self-administrable diagnostic tests that are readable at the point of care or at home4 7d7 ,incorporating diagnostics supply chain resiliency into influenza pandemic planning ,the ,assistant ,secretary for ,preparedness and ,response1 in collaboration with the ,commissioner of ,food and ,drugs1 the ,director of the ,centers for ,disease ,control and ,prevention1 the ,secretary of ,commerce1 and the ,secretary of ,transportation1 shall-- 7#a7 incorporate diagnostics supply chain resiliency into influenza pandemic planning that supports a health care system that tests to treat and bolsters testing and vaccine delivery supply chains2 and 7#b7 not later than #a year after the date of enactment of this ,act1 publish a plan for rapidly expanding public and private diagnostic testing capacity 7including at clinical laboratories1 at public health department laboratories1 and by means of self-testing7 in an influenza pandemic1 including addressing transportation infrastructure1 the need for sterilization1 and sourcing critical raw materials1 components1 and parts4 7e7 ,scaling up prophylactic influenza antibody products that address gaps in coverage ,the ,director of the ,biomedical ,advanced ,research and ,development ,authority may conduct or support preventive approaches1 including those still in preclinical and clinical stages1 to rapidly scale up preexposure prophylactic influenza antibody products that address influenza infection4 7f7 ,modernizing potency assays ,the ,commissioner of ,food and ,drugs shall work with vaccine manufacturers to modernize potency assays across a variety of manufacturing technologies so as to reduce by #f weeks the period required to first evaluate new vaccine candidates during a pandemic4 7g7 ,improved influenza therapeutics ,the ,director of the ,biomedical ,advanced ,research and ,development ,authority may conduct or support improved influenza therapeutics that-- 7#a7 are more broadly protective2 and 7#b7 meet the needs of high-risk and high-exposure patients4 #e4 ,increasing influenza vaccine1 therapeutics1 and testing access and coverage across all populations 7a7 ,annual report on public communication strategy ,the ,director of the ,centers for ,disease ,control and ,prevention shall submit an annual report to ,congress on the public communication strategy of the ,centers to increase public confidence in the safety and effectiveness of vaccines4 7b7 ,sense of ,congress ,it is the sense of ,congress that the ,director of the ,national ,institutes of ,health1 the ,director of the ,centers for ,disease ,control and ,prevention1 the ,secretary of ,defense1 the ,secretary of ,veterans ,affairs1 the ,administrator of the ,centers for ,medicare ,medicaid ,services1 and the ,commissioner of ,food and ,drugs should support research using large data sets from multiple sources of health data to further support and evaluate vaccine safety and effectiveness over multiple influenza seasons4 7c7 ,addressing misinformation and disinformation 7#a7 ,in general ,the ,secretary of ,health and ,human ,services shall create partnerships to address misinformation and disinformation with respect to influenza vaccines4 7#b7 ,requirements ,the partnerships under paragraph 7#a7 shall-- 7,a7 build on lessons learned from ,,covid-#ai2 and 7,b7 allow for dissemination of best practices and lessons learned between partnering organizations4 7#c7 ,members ,the members of the partnerships under paragraph 7#a7 shall include representatives of organizations with experience working with vulnerable populations1 including-- 7,a7 individuals with chronic health conditions2 7,b7 older individuals2 7,c7 parents of young children2 7,d7 pregnant people2 7,e7 ,tribal communities2 and 7,f7 racial and ethnic minorities4 7#d7 ,conferring with partnering organizations ,the ,secretary of ,health and ,human ,services shall confer with organizations represented in partnerships under paragraph 7#a7-- 7,a7 in advance of each seasonal influenza season1 on messaging and communications2 and 7,b7 at the end of each seasonal influenza season1 on best practices and lessons learned4 7#e7 ,report to ,congress ,not later than one year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall report to ,congress on the partnerships created1 and activities conducted1 under this section4 7d7 ,communications public-,private partnership 7#a7 ,in general ,not later than #f months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall implement a targeted demonstration project that provides for the establishment of a communications public-private partnership initiative for increasing vaccine confidence4 7#b7 ,requirements ,the demonstration project under paragraph 7#a7 shall-- 7,a7 be implemented through an independent1 nongovernmental1 nonprofit entity2 7,b7 focus on individuals with chronic illness or other comorbidities who tend to have worse clinical outcomes from influenza 7such as individuals with heart disease or diabetes1 and racial and ethnic minorities72 7,c7 support behavioral research around sources of vaccine hesitancy2 and 7,d7 develop and implement a targeted1 multimodal communications campaign1 using internet platforms1 television1 and nontraditional targeted social media and community outreach in an effort to reach individuals who may be especially vaccine hesitant4 7#c7 ,report ,not later than #f months after completion of the demonstration project under paragraph 7#a71 the ,secretary of ,health and ,human ,services shall-- 7,a7 prepare a report on the demonstration project1 including an evaluation of the project's methods1 findings1 and results2 and 7,b7 make such report publicly available on the website of the ,department of ,health and ,human ,services4 7e7 ,incorporating health equity into seasonal and pandemic influenza planning and response ,the ,director of the ,centers for ,disease ,control and ,prevention and the ,assistant ,secretary for ,preparedness and ,response shall-- 7#a7 incorporate health equity into the seasonal and pandemic influenza planning and response programs overseen by such officials2 and 7#b7 in so doing-- 7,a7 emphasize the inclusion of all populations2 and 7,b7 include strategies to reach communities of color1 communities with lower socioeconomic status1 seniors1 and individuals with disabilities1 including addressing barriers to vaccinations1 therapeutics1 and diagnostics in the point-of-care and at-home self-testing settings4 7f7 ,expanding access to influenza treatment and adopting lessons learned from ,,covid-#ai ,federal ,retail ,pharmacy ,program 7#a7 ,report ,not later than #f months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall submit a report to the ,congress on lessons learned from the ,,covid-#ai ,federal ,retail ,pharmacy ,program1 including aspects of the program that could be applied with respect to multianalyte tests that target ,,covid-#ai as well as influenza and other upper respiratory viruses4 7#b7 ,demonstration project 7,a7 ,in general ,not later than one year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall initiate an influenza test-to-treat demonstration project that builds on the test-to-treat model employed for ,,covid-#ai4 7,b7 ,length2 locations ,this demonstration project under subparagraph 7,a7 shall run for the length of one seasonal influenza season and be based in one or more of the following locations3 7i7 ,facilities that serve vulnerable populations1 such as populations who are in long-term care facilities1 are #fe years of age or older1 may have other medical conditions1 and will be in unavoidable close contact with others4 7ii7 ,federal health care facilities that serve at-risk and vulnerable communities1 such as ,indian ,health ,service clinics1 ,federally qualified health centers 7as defined in section #ahfa7;aa7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7aa7771 and facilities of the ,department of ,veterans ,affairs4 7iii7 ,existing ,,covid-#ai test-to-treat sites at retail pharmacies1 potentially in specific geographic areas with historically high mortality from influenza4 7iv7 ,other appropriate locations identified by the ,secretary of ,health and ,human ,services1 in consultation with external stakeholder organizations1 to test the operational feasibility and impact of influenza test-to-treat programs4 7#c7 ,report ,not later than #f months after completion of the demonstration project under paragraph 7#b71 the ,secretary of ,health and ,human ,services shall-- 7,a7 prepare a report on the demonstration project under paragraph 7#b71 including an evaluation of the project's methods1 findings1 and results2 and 7,b7 make such report publicly available on the website of the ,department of ,health and ,human ,services4 7g7 ,creating administration pathways ,the ,secretary of ,health and ,human ,services may award grants to ,states to create administration pathways for pharmacy personnel to administer influenza vaccines1 tests1 and therapeutics1 in order to increase vaccination1 testing1 and relevant treatment as needed for adults and children4 7h7 ,strategic ,national ,stockpile ,the ,secretary of ,health and ,human ,services shall incorporate into the ,strategic ,national ,stockpile under section #cai;,f-#b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;b7 products needed to respond to pandemic influenza1 including through-- 7#a7 dynamic management of antivirals2 7#b7 vendor-managed inventory of testing equipment and supplies2 7#c7 replenishment of aging antivirals1 testing equipment1 supplies1 and other products2 and 7#d7 diversification of stockpiled products4 7i7 ,monitoring and distributing influenza antiviral supplies ,the ,secretary of ,health and ,human ,services shall-- 7#a7 monitor influenza antiviral supplies throughout the country and publicly report challenges in availability in any region1 ,state1 county1 or metropolitan area2 and 7#b7 establish a process1 to be used in the case of a pandemic or during times when influenza antiviral supply availability is challenged1 to ensure rapid and effective distribution of products to areas of urgent need in close coordination with manufacturers1 distributors1 and ,state and local health officials4 7j7 ,plan for ensuring access to appropriate influenza therapeutics1 preexposure prophylaxis1 and diagnostics 7#a7 ,in general ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall publish a plan for ensuring access to appropriate influenza therapeutics1 preexposure prophylaxis influenza antibody products1 and influenza diagnostics1 including during times when availability is challenged in certain regions or localities1 for-- 7,a7 high-risk patients1 such as nursing home and pediatric patients2 7,b7 high-exposure patients1 such as first responders and health care workers2 and 7,c7 low-income individuals1 individuals covered under the ,medicaid program under title ,,xix of the ,social ,security ,act 7#db ,u4,s4,c4 #acif et seq471 uninsured individuals1 ,tribal communities1 and other underserved populations4 7#b7 ,communications efforts ,the plan required by paragraph 7#a7 shall include communications efforts to educate the public about the benefits of early use of influenza diagnostics1 therapeutics4 and preexposure prophylaxis products4 7k7 ,,gao review on transferring ,,covid-#ai technologies 7#a7 ,in general ,not later than #f months after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall conduct a review of the technology and systems utilized by the ,centers for ,disease ,control and ,prevention1 the ,administration for ,strategic ,preparedness and ,response1 ,operation ,warp ,speed1 the ,countermeasure ,acceleration ,group1 ,h-,,core1 and other current and historical departments and agencies involved in the ,,covid-#ai response for surveillance and tracking of ,,covid-#ai cases1 treatments1 and vaccines1 with particular focus on-- 7,a7 disease surveillance2 7,b7 vaccine surveillance2 and 7,c7 vaccine effectiveness4 7#b7 ,scope ,the review under paragraph 7#a7 shall include-- 7,a7 assessment of which technology and systems can be applied to1 or can be altered to apply to1 influenza and other infectious diseases2 and 7,b7 formulation of recommendations for applying and altering technologies and systems as described in subparagraph 7,a74 7#c7 ,report by ,,hhs to ,congress ,not later than #cj days after completion of the review required by paragraph 7#a71 the ,secretary of ,health and ,human ,services shall submit a report to ,congress on the timeline and actions necessary to implement the recommendations formulated under paragraph 7#b77;,b74 #f4 ,authorizing sustainable funding for the influenza ecosystem 7a7 ,influenza ,planning and ,response ,program ,there is authorized to be appropriated #bca1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for programs and activities of the ,centers for ,disease ,control and ,prevention relating to influenza planning and response4 7b7 ,strategic ,national ,stockpile ,there is authorized to be appropriated #ife1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for the ,strategic ,national ,stockpile under section #cai;,f-#b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;b74 7c7 ,hospital ,preparedness ,program ,there is authorized to be appropriated #cje1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for ,hospital ,preparedness ,program of the ,assistant ,secretary for ,preparedness and ,response4 7d7 ,universal ,flu ,vaccine ,research ,there is authorized to be appropriated #bgj1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for research of the ,national ,institutes of ,health to develop a universal flu vaccine4 7e7 ,immunization ,program ,there is authorized to be appropriated #fhb1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for the immunization program of the ,centers for ,disease ,control and ,prevention under section #cag of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;b74 7f7 ,public ,health ,emergency ,preparedness ,program ,there is authorized to be appropriated #gce1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for the ,public ,health ,emergency ,preparedness ,program of the ,centers for ,disease ,control and ,prevention4 7g7 ,infectious ,disease ,rapid ,response ,reserve ,fund ,there is authorized to be appropriated #ce1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for the ,infectious ,disease ,rapid ,response ,reserve ,fund of the ,centers for ,disease ,control and ,prevention4 7h7 ,data ,modernization ,initiative ,there is authorized to be appropriated #age1jjj1jjj for fiscal year #bjbd and each subsequent fiscal year for the ,public ,health ,data ,modernization ,initiative of the ,centers for ,disease ,control and ,prevention4